Oneness Biotech Co., Ltd. (4743.TWO)
TWD 57.4
(-6.06%)
TWD 57.4
(-6.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.09 Billion TWD | -340.37% |
| 2022 | 456.22 Million TWD | 216.66% |
| 2021 | -391.06 Million TWD | -59.77% |
| 2020 | -244.76 Million TWD | 23.51% |
| 2019 | -320 Million TWD | -142.09% |
| 2018 | -132.18 Million TWD | 4.97% |
| 2017 | -139.09 Million TWD | -22.92% |
| 2016 | -113.15 Million TWD | -16.4% |
| 2015 | -97.2 Million TWD | 17.74% |
| 2014 | -118.17 Million TWD | 3.92% |
| 2013 | -122.99 Million TWD | -52.03% |
| 2012 | -80.9 Million TWD | -4.52% |
| 2011 | -77.39 Million TWD | -212.42% |
| 2010 | -24.77 Million TWD | 9.27% |
| 2009 | -27.3 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -260.38 Million TWD | 12.5% |
| 2024 Q2 | -281.24 Million TWD | -8.01% |
| 2023 Q1 | -267.77 Million TWD | 58.72% |
| 2023 Q2 | -324.9 Million TWD | -21.33% |
| 2023 FY | -1.09 Billion TWD | -340.37% |
| 2023 Q3 | -222.86 Million TWD | 31.41% |
| 2023 Q4 | -297.58 Million TWD | -33.53% |
| 2022 Q3 | 278.3 Million TWD | -36.08% |
| 2022 Q1 | 391.16 Million TWD | 199.23% |
| 2022 FY | 456.22 Million TWD | 216.66% |
| 2022 Q4 | -648.66 Million TWD | -333.07% |
| 2022 Q2 | 435.41 Million TWD | 11.31% |
| 2021 Q2 | -170.59 Million TWD | 38.09% |
| 2021 Q3 | -213.48 Million TWD | -25.14% |
| 2021 FY | -391.06 Million TWD | -59.77% |
| 2021 Q4 | 130.72 Million TWD | 161.23% |
| 2021 Q1 | -275.56 Million TWD | -35.58% |
| 2020 Q2 | -195.59 Million TWD | -34.87% |
| 2020 FY | -244.76 Million TWD | 23.51% |
| 2020 Q4 | -203.24 Million TWD | -57.18% |
| 2020 Q1 | -145.02 Million TWD | -7.0% |
| 2020 Q3 | -129.3 Million TWD | 33.89% |
| 2019 Q2 | -53.11 Million TWD | -40.91% |
| 2019 Q1 | -37.69 Million TWD | -0.36% |
| 2019 Q4 | -135.52 Million TWD | -58.72% |
| 2019 FY | -320 Million TWD | -142.09% |
| 2019 Q3 | -85.38 Million TWD | -60.75% |
| 2018 Q4 | -37.56 Million TWD | 14.22% |
| 2018 Q1 | -26.38 Million TWD | 29.05% |
| 2018 Q2 | -24.45 Million TWD | 7.3% |
| 2018 Q3 | -43.78 Million TWD | -79.05% |
| 2018 FY | -132.18 Million TWD | 4.97% |
| 2017 Q2 | -32.78 Million TWD | 3.93% |
| 2017 FY | -139.09 Million TWD | -22.92% |
| 2017 Q4 | -37.18 Million TWD | -6.21% |
| 2017 Q3 | -35 Million TWD | -6.8% |
| 2017 Q1 | -34.12 Million TWD | 6.36% |
| 2016 Q4 | -36.43 Million TWD | -31.47% |
| 2016 Q3 | -27.71 Million TWD | 1.56% |
| 2016 Q2 | -28.15 Million TWD | -35.07% |
| 2016 Q1 | -20.84 Million TWD | 32.84% |
| 2016 FY | -113.15 Million TWD | -16.4% |
| 2015 Q3 | -20.98 Million TWD | 6.95% |
| 2015 Q2 | -22.55 Million TWD | 0.33% |
| 2015 Q1 | -22.62 Million TWD | 55.48% |
| 2015 FY | -97.2 Million TWD | 17.74% |
| 2015 Q4 | -31.03 Million TWD | -47.87% |
| 2014 Q4 | -50.83 Million TWD | -72.58% |
| 2014 FY | -118.17 Million TWD | 3.92% |
| 2014 Q3 | -29.45 Million TWD | -56.17% |
| 2014 Q2 | -18.86 Million TWD | 0.92% |
| 2014 Q1 | -19.03 Million TWD | 56.84% |
| 2013 Q3 | -23.29 Million TWD | 31.31% |
| 2013 Q4 | -44.1 Million TWD | -89.35% |
| 2013 FY | -122.99 Million TWD | -52.03% |
| 2013 Q2 | -33.91 Million TWD | -56.34% |
| 2013 Q1 | -21.69 Million TWD | 12.1% |
| 2012 Q3 | -17.21 Million TWD | 10.23% |
| 2012 Q4 | -24.67 Million TWD | -43.33% |
| 2012 Q1 | -19.86 Million TWD | 25.64% |
| 2012 FY | -80.9 Million TWD | -4.52% |
| 2012 Q2 | -19.17 Million TWD | 3.47% |
| 2011 FY | -77.39 Million TWD | -212.42% |
| 2011 Q1 | -15.81 Million TWD | -252.53% |
| 2011 Q2 | -14.05 Million TWD | 11.14% |
| 2011 Q3 | -20.81 Million TWD | -48.07% |
| 2011 Q4 | -26.71 Million TWD | -28.37% |
| 2010 Q2 | -13.22 Million TWD | -31.22% |
| 2010 FY | -24.77 Million TWD | 9.27% |
| 2010 Q4 | 10.37 Million TWD | 187.57% |
| 2010 Q1 | -10.07 Million TWD | 0.0% |
| 2010 Q3 | -11.84 Million TWD | 10.45% |
| 2009 FY | -27.3 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 489.08% |
| Level Biotechnology Inc. | 67.55 Million TWD | 1723.379% |
| TaiMed Biologics Inc. | -166.23 Million TWD | -559.699% |
| GlycoNex Incorporation | -259.86 Million TWD | -322.0% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | -378.28% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 47.525% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -48573.99% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -1190.238% |
| Visgeneer Inc. | -21.15 Million TWD | -5082.783% |
| Neith Corporation | -48.85 Million TWD | -2144.698% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | -191.947% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 9.656% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -16490.393% |
| Enimmune corporation | -243.47 Million TWD | -350.406% |
| TaiRx, Inc. | -214.69 Million TWD | -410.783% |
| CHO Pharma, Inc. | -268.99 Million TWD | -307.67% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 1831.468% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | -1421.062% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 424.703% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 4638.635% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -2417.505% |
| RBC Bioscience Corporation | 14.53 Million TWD | 7642.644% |
| NaviFUS Corp. | -76.42 Million TWD | -1334.885% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | -57.987% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -1649.478% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -1566.097% |
| Sagittarius Life Science Corp | -64.37 Million TWD | -1603.469% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | -1453.689% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -1074.922% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | -521.173% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 1459.16% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -1519.902% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 0.018% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -1832.413% |
| AP Biosciences Inc | -347.47 Million TWD | -215.596% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 222.556% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 428.25% |
| EirGenix Inc. | -1.03 Billion TWD | -6.264% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -38732.33% |
| Mycenax Biotech Inc. | -602.1 Million TWD | -82.133% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -2310.059% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -2543.617% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | -1190.998% |
| VBI | -16.13 Million TWD | -6697.824% |
| BiOptic Inc. | 44.05 Million TWD | 2589.331% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -1067.181% |
| Sinew Pharma Inc. | -186.25 Million TWD | -488.782% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 786.175% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 11.067% |
| 3D Global Biotech Inc. | -62.85 Million TWD | -1644.746% |
| Intech Biopharm Corporation | -304.39 Million TWD | -260.263% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | -546.763% |
| TCI GENE Inc. | 10.04 Million TWD | 11012.777% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | -761.74% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | -252.487% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | -416.779% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 32034.333% |
| PharmaEngine, Inc. | 277.18 Million TWD | 495.632% |
| Savior Lifetec Corporation | -2.42 Million TWD | -45215.083% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | -527.723% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | -790.45% |
| Acepodia, Inc. | -435.97 Million TWD | -151.534% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | -124.738% |